XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.4

Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Schedule of the impact of the immaterial correction of an error

​

​	​	​	​	​	​	​	​	​	​
​	​	As of September 30, 2022
​	​	As Previously		​	​	​	​	​	​
​	​	Reported		​	Adjustment		​	As Restated
​	​	(in thousands)
Derivative warrant liability	​	$	—	​	$	5,558	​	$	5,558
Total liabilities	​	​	96,094	​	​	5,558	​	​	101,652
Additional paid-in capital	​	​	345,253	​	​	(9,126)	​	​	336,127
Accumulated deficit	​	​	(291,353)	​	​	3,574	​	​	(287,779)
Total stockholders’ equity	​	​	53,906	​	​	(5,558)	​	​	48,348

​

​

​

​	​	​	​	​	​	​	​	​	​
​	​	Three Months Ended
​	​	September 30, 2022
​	​	As Previously		​	​	​	​	​	​
​	​	Reported		​	Adjustment		​	As Restated
​	​	(in thousands)
Statement of Operation data	​	​	​	​	​	​	​	​	​
Gain on derivative warrant liabilities	​	$	—	​	$	2,191	​	$	2,191
Total other (expense) income	​	​	(1,228)	​	​	2,180	​	​	952
Loss before income tax	​	​	(2,881)	​	​	2,180	​	​	(701)
Net loss	​	​	(2,881)	​	​	2,180	​	​	(701)
Basic and diluted net loss per common share	​	​	(1.14)	​	​	0.86	​	​	(0.28)
​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​	​	​
Statement of Cash Flow data	​	​	​	​	​	​	​	​	​
Net loss	​	$	(2,881)	​	$	2,180	​	$	(701)
Gain on derivative warrant liabilities	​	​	—	​	​	2,191	​	​	2,191
​	​	​	​	​	​	​	​	​	​
Net loss by segment	​	​	​	​	​	​	​	​	​
Rx Segment	​	$	(2,054)	​	$	2,180	​	$	126
Consumer Health Segment	​	​	(827)	​	​	—	​	​	(827)
Consolidated net loss	​	​	(2,881)	​	​	2,180	​	​	(701)

​

​

​	​	​	​	​	​	​	​	​	​
​	​	As of June 30, 2022
​	​	As Previously		​	​	​	​	​	​
​	​	Reported		​	Adjustment		​	As Adjusted
​	​	(in thousands)
Derivative warrant liability	​	$	—	​	$	1,796	​	$	1,796
Total liabilities	​	​	91,531	​	​	1,784	​	​	93,315
Additional paid-in capital	​	​	334,560	​	​	(3,174)	​	​	331,386
Accumulated deficit	​	​	(288,472)	​	​	1,394	​	​	(287,078)
Total stockholders’ equity	​	​	46,092	​	​	(1,784)	​	​	44,308

​

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

+ Details

Name:	us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration